AKT1 and breast carcinoma: In the biological assays, SH1, SH4, and SH11 exhibited cytotoxic activity in the MCF-7 human mammary carcinoma cell line via the inhibition of the PI3K/Akt and ERK 1/2 cell signaling pathways.